U.S. Electronic Equipment and Components Stock News

CG Oncology (CGON) has just closed out FY 2025 with Q4 revenue of US$2.3 million and a basic EPS loss of US$0.52, alongside a net income loss of US$41.3 million, as the company continues to invest heavily in its pipeline. Over the last twelve months, revenue has summed to US$4.0 million and basic EPS has come in at a loss of US$2.08. This gives investors a clear view of a business that is still in a development phase and running with intentionally thin margins while it pushes its late stage...

If you are wondering whether Envista Holdings at US$24.29 offers good value or is already fully priced, the recent share performance gives you a useful starting point. The stock has pulled back 6.4% over the last 7 days and 4.0% over the last 30 days. It sits 12.0% higher year to date and 36.7% above where it was a year ago, while the 3 year and 5 year returns of 26.7% and 44.7% highlight a tougher longer term journey. Recent coverage has focused on Envista Holdings as a dental equipment and...

Assurant (AIZ) just paired a strong Q1 2026 earnings beat with higher full year guidance and continued share repurchases, putting the spotlight on how its Global Lifestyle driven momentum might affect the stock. See our latest analysis for Assurant. Despite the strong Q1 surprise and ongoing buybacks, Assurant’s recent trading has been mixed, with a 6.86% 1 month share price return but a 1.65% year to date share price decline. In contrast, the 1 year total shareholder return of 21.86% and 3...

Earnings picture during a key regulatory phase Vera Therapeutics (VERA) reported a first quarter net loss of US$121.03 million, compared with US$51.69 million a year earlier, as it pushes atacicept toward potential approval for IgA nephropathy. Basic and diluted loss per share from continuing operations came in at US$1.69, versus US$0.81 in the prior year period. This provides a snapshot of how much capital the company is currently investing ahead of the July 7, 2026 FDA decision. See our...

What PNC’s Recent Returns Tell You PNC Financial Services Group (PNC) has moved in different directions across timeframes, with a 1 day return of about a 1.4% decline, losses over the past 3 months, and a 1 year total return of 35.9%. See our latest analysis for PNC Financial Services Group. Recent share price moves have cooled slightly, with a 30 day share price return of 2.5% against a 90 day share price return of a 9.6% decline, while the 1 year total shareholder return of 36.0% and 3...

Wondering if Labcorp Holdings at around US$258 a share still offers value, or if most of the opportunity is already priced in? This article walks through the key signals you can use to judge that for yourself. The stock has been fairly steady over the last week with a 0.5% return, has a 4.1% decline over the past month, yet sits on a 4.8% return over 1 year and 41.6% over 3 years. This raises the question of whether the current price reflects the business fundamentals. Recent headlines...

How Avery Dennison (AVY) Has Been Trading Recently Avery Dennison (AVY) has seen mixed share performance recently, with a 0.7% decline over the past day, a 1% gain over the past week, and a 1.2% decline over the past month. Over the past 3 months, the stock shows a 13.6% decline, with a year to date return of negative 9.3% and a 1 year total return of negative 2.3%. Longer term, the 3 year total return stands at 1.5%, while the 5 year total return is negative 18.3%. See our latest analysis...

In early May 2026, Jackson Financial Inc. reported first-quarter 2026 results showing revenue of US$2,902 million and a net loss of US$424 million, while also continuing to return capital through dividends and share repurchases under its multi-year buyback program. Beneath the headline loss, the company highlighted strong retail annuity momentum, a very large share repurchase completion since 2021, and a new TPG partnership aimed at supporting product diversification and capital...

Ubiquiti (UI) has put up another big quarter, with Q2 2026 revenue of US$814.9 million and basic EPS of US$3.86, while trailing 12 month EPS sits at US$14.69 on revenue of about US$3.0 billion and earnings growth over that period is described as a 99.7% jump. The company has seen quarterly revenue move from US$599.9 million and EPS of US$2.26 in Q2 2025 to US$814.9 million and EPS of US$3.86 in Q2 2026, and trailing 12 month net profit margin is now stated at 29.9% versus 20.7% a year...

Lattice Semiconductor reported past Q1 2026 results with revenue of US$170.9 million and net income of US$21.82 million, beating market expectations and issuing Q2 revenue guidance of US$175 million to US$195 million. The company also announced an agreement to acquire AMI for about US$1.65 billion, aiming to combine low-power FPGAs with firmware and manageability software to broaden its role in AI servers and cloud infrastructure. Next, we’ll examine how this earnings beat and AMI...

Navios Maritime Partners L.P. recently announced that its Board of Directors approved a cash distribution of US$0.06 per unit for the quarter ended March 31, 2026, a 20% increase over the prior quarter, payable on May 14, 2026 to holders of record as of May 11, 2026. This higher quarterly payout, equivalent to an annualized US$0.24 per unit, highlights management’s willingness to return more cash to unitholders and may influence how investors assess its income profile. We will now examine...

Goodyear Tire & Rubber (GT) reported first quarter 2026 results, with sales of US$3,881 million and a net loss of US$249 million, as tyre volumes and input costs weighed on performance. See our latest analysis for Goodyear Tire & Rubber. At a share price of US$6.86, Goodyear’s 1 day share price return of 6.03% decline and 7 day share price return of 3.11% decline came after the first quarter loss and ongoing cost pressures. The 1 year total shareholder return of 37.29% decline underlines that...

Wondering whether Clover Health Investments at US$2.82 is still a bargain or already pricing in its prospects? This breakdown will help you judge what you are really paying for. The stock has had a strong run over shorter periods, with returns of 2.5% over 7 days, 48.4% over 30 days and 17.0% year to date. However, the 1 year return sits at a 24.8% decline and the 3 year return is very large at 196.7% compared to a 61.2% decline over 5 years. Recent headlines have focused on the company as a...

National Energy Services Reunited stock reaction National Energy Services Reunited (NESR) has drawn attention after recent trading that left the stock at US$23.35, with short term moves contrasting with gains over the month and the past 3 months. See our latest analysis for National Energy Services Reunited. Although the 1 day share price return of 5.81% and 7 day share price return of 6.38% are weak, the 1 month and year to date share price returns of 7.70% and 47.88% alongside a very large...

Oil-driven sector move puts Vail Resorts (MTN) in focus Vail Resorts (MTN) climbed 3% after crude oil prices fell sharply on hopes for a deal to reopen the Strait of Hormuz, a move that could ease fuel related costs across travel and leisure stocks. See our latest analysis for Vail Resorts. Today’s move sits against a weaker backdrop, with a 30 day share price return of 3.43% and a year to date share price return of a 6.49% decline, while the 5 year total shareholder return of a 50.96%...

The Andersons, Inc. reported first-quarter 2026 sales of US$2,627.27 million, with net income rising to US$33.19 million and diluted EPS from continuing operations increasing to US$0.97, marking its strongest first quarter on record. This profit surge was fueled by improved Agribusiness and Renewables performance and the recognition of US$26.2 million in Section 45Z clean fuel production credits, alongside ongoing investments in soybean meal export capacity and ethanol plant...

Flex (FLEX) is in focus after reporting Q4 and fiscal 2026 results that exceeded analyst expectations, and pairing the earnings beat with plans to spin off its Cloud and Power Infrastructure segment. See our latest analysis for Flex. The share price has been on a strong run, with a 30 day share price return of 95.05% and a year to date share price return of 108.93%. The one year total shareholder return of 245.39% points to powerful momentum that recent earnings, guidance and the spin off...

Lyft (LYFT) closed FY 2025 with fourth quarter revenue of US$1,592.7 million and basic EPS of US$6.88, setting a high bar for a year in which trailing 12 month EPS reached US$6.92 and revenue stood at US$6.3 billion alongside very large year over year earnings growth and a 45% net profit margin. Over the past six quarters, the company has seen quarterly revenue move from US$1,522.7 million in Q3 2024 to between US$1,450.2 million and US$1,685.2 million across FY 2025, while basic EPS ranged...

Why Exelixis stock is on investors’ radar after Q1 2026 Exelixis (EXEL) is back in focus after first quarter 2026 earnings, with revenue of US$610.81 million, net income of US$210.47 million, and FDA progress on zanzalintinib alongside active share repurchases. See our latest analysis for Exelixis. The stock has cooled slightly after earnings, with a 1 day share price decline of 5.11% to US$46.21. However, a 1 year total shareholder return of 26.60% and a 3 year total shareholder return of...

Recent performance snapshot for VNET Group (NasdaqGS:VNET) With no single headline event driving attention, VNET Group (NasdaqGS:VNET) is back on investors’ radar after mixed recent returns and improving annual revenue and net income figures, which contrast with its current loss-making position. See our latest analysis for VNET Group. VNET Group’s share price has been choppy, with a 7.82% 7 day share price return and 12.70% 30 day share price return contrasting with a 20% 90 day share price...

In the first quarter ended March 31, 2026, Xenon Pharmaceuticals reported a net loss of US$102.3 million, or US$1.17 per share, while highlighting that it still has no marketed products and relies on collaboration revenues. More importantly for the company’s evolution, Xenon released positive Phase 3 X-TOLE2 data for its epilepsy candidate azetukalner and outlined plans to submit a New Drug Application to the FDA in the third quarter of 2026, underpinned by an expanded cash position of...

Expedia Group (EXPE) has wrapped up FY 2025 with fourth quarter revenue of US$3,547 million and basic EPS of US$1.67, alongside trailing twelve month revenue of US$14.7 billion and EPS of US$10.32. This provides a clear snapshot of scale and earnings power. Over recent quarters, the company has seen revenue range from US$2,988 million to US$4,412 million and quarterly EPS move between a loss of US$1.55 and a high of US$7.75. This gives investors a wide band of outcomes to weigh against the...

Context for Intuitive Surgical’s recent share performance Intuitive Surgical (ISRG) has drawn renewed attention after a period where the stock is roughly flat over the past month and shows a negative move over the past 3 months, prompting investors to reassess its fundamentals. With a market value near US$160b and annual revenue of US$10.58b, the company sits at scale in robotic and minimally invasive medical equipment, giving investors plenty of hard numbers to weigh against recent share...

CoreWeave (CRWV) has just wrapped up FY 2025 with Q4 total revenue of US$1.6b, a basic EPS loss of US$0.89 and net income loss of US$452.0m. This caps off a year in which trailing twelve month revenue reached US$5.1b alongside a TTM basic EPS loss of US$2.75. Over the past six reported quarters, the company has seen revenue move from US$584.0m in Q3 2024 to US$1.6b in Q4 2025. During the same period, quarterly basic EPS has ranged between a loss of US$0.22 and a loss of US$1.82, so the latest...